Option Care Health (OPCH) PT Raised to $40 at Jefferies

Jefferies analyst Brian Tanquilut raised the price target on Option Care Health (NASDAQ: OPCH) to $40.00 (from $35.00) while maintaining a Buy rating.

The analyst comments "We remain positive on OPCH and point to the underlying normalized growth implied in FY25 guide as an indicator of its robust outlook, which is not adequately reflected in the stock's current valuation. In addition to strong sector fundamentals, proven mgmt execution, and likely EBITDA upside, the strengthening of OPCH's FCF, which we expect mgmt to harness to fund a more aggressive share buyback, further bolsters our positive conviction on the name. PT to $40."

You May Also Be Interested In

• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
• NANO Nuclear Announces Participation in Several Investor Conferences
• New Street Research Upgrades Micron Technology (MU) to Buy